MedolifeRx:Will be a Potential Big Pharma BO...as it will be Cheaper for Them to Acquire The Whole Pie. Research/Pre-clinicals Toxicity/Efficacy Everything are already Done with Production and Distribution in Place.
For Future Insti-Buyers, it will be like Purchasing @ $5/sh equivalent to Retail Investors...purchasing now @ $0.10/sh
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.